United States exports of Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient was $79,135.00K and quantity 1,254,150Kg. United States exported Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient to France ($15,398.70K , 133,411 Kg), Korea, Rep. ($7,567.02K , 80,660 Kg), Chile ($6,223.08K , 206,355 Kg), Australia ($6,025.92K , 40,894 Kg), Belgium ($4,808.76K , 39,049 Kg).Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient imports by country in 2021
| Reporter | TradeFlow | ProductCode | Product Description | Year | Partner | Trade Value 1000USD | Quantity | Quantity Unit |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | World | 79,135.00 | 1,254,150 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | France | 15,398.70 | 133,411 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Korea, Rep. | 7,567.02 | 80,660 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Chile | 6,223.08 | 206,355 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Australia | 6,025.92 | 40,894 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Belgium | 4,808.76 | 39,049 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | China | 3,967.75 | 34,863 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Panama | 3,920.18 | 52,366 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Canada | 3,866.13 | 131,046 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Mexico | 3,322.03 | 120,535 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Argentina | 3,143.50 | 48,381 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Brazil | 2,822.20 | 63,857 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Colombia | 2,419.03 | 70,355 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Saudi Arabia | 2,010.00 | 25,854 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Barbados | 1,305.00 | 250 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | United Arab Emirates | 1,168.38 | 43,372 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Switzerland | 1,105.26 | 2,033 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Poland | 1,003.99 | 4,879 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Germany | 714.73 | 13,063 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Hong Kong, China | 690.64 | 2,434 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Peru | 618.48 | 5,863 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Hungary | 598.54 | 1,105 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | United Kingdom | 557.23 | 2,644 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Ireland | 465.01 | 15,041 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Israel | 416.33 | 962 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Singapore | 387.54 | 46,925 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Jordan | 373.79 | 8,168 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Russian Federation | 328.84 | 2,280 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | New Zealand | 323.34 | 3,257 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Spain | 311.69 | 1,191 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Norway | 276.52 | 5,105 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Qatar | 241.73 | 4,327 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Sweden | 226.19 | 493 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Jamaica | 215.10 | 4,392 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Dominican Republic | 211.91 | 1,017 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Japan | 176.36 | 1,165 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Denmark | 163.45 | 442 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Italy | 154.12 | 582 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Vietnam | 130.46 | 532 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Other Asia, nes | 121.61 | 715 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Lebanon | 118.67 | 2,570 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Netherlands | 117.13 | 410 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Portugal | 102.55 | 382 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | India | 98.40 | 325 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Philippines | 89.83 | 4,643 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Bermuda | 76.65 | 43 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Venezuela | 63.41 | 1,157 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Cayman Islands | 58.77 | 491 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Turkey | 56.02 | 534 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Bahrain | 49.55 | 1,025 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | South Africa | 43.28 | 197 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Thailand | 37.38 | 58 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Egypt, Arab Rep. | 36.38 | 750 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Czech Republic | 35.39 | 143 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Austria | 34.42 | 202 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Uruguay | 32.56 | 14,786 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Costa Rica | 31.35 | 41 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Lithuania | 22.08 | 66 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Mauritius | 21.82 | 105 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Malaysia | 21.35 | 355 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | St. Lucia | 20.56 | 332 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Kuwait | 19.69 | 528 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Oman | 17.92 | 13 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Slovenia | 16.49 | 170 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Ghana | 15.28 | 588 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Senegal | 15.20 | 485 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Greece | 14.79 | 302 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Bhutan | 12.78 | 90 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Grenada | 11.41 | 23 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Fiji | 10.99 | 26 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Ukraine | 10.26 | 60 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Brunei | 9.70 | 3,197 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Aruba | 8.14 | 40 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | St. Kitts and Nevis | 7.16 | 7 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Guyana | 6.16 | 17 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Indonesia | 4.49 | 4 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Croatia | 3.40 | 9 | Kg |
| United States | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2021 | Slovak Republic | 3.04 | 109 | Kg |
HS Nomenclature used HS 1988/92 (H0)HS Code 300630: Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patientPlease note: Exports is gross exports and Imports is gross imports